Nancy Lynn MD Snyderman's Net Worth

$1.56 Million

Estimate Recalculated Nov 7, 2024 12:13PM EST

Who is Nancy Lynn MD Snyderman?

Nancy Lynn MD Snyderman has an estimated net worth of $1.56 Million. This is based on reported shares across multiple companies, which include Future Health ESG Corp., Axonics Modulation Technologies, Inc., Alkermes plc., and Lyra Therapeutics, Inc..

SEC CIK

Nancy Lynn MD Snyderman's CIK is 0001675198

Past Insider Trading and Trends

2023 was Nancy Lynn MD Snyderman's most active year for acquiring shares with 16 total transactions. Nancy Lynn MD Snyderman's most active month to acquire stocks was the month of May. 2021 was Nancy Lynn MD Snyderman's most active year for disposing of shares, totalling 5 transactions. Nancy Lynn MD Snyderman's most active month to dispose stocks was the month of May. 2019 saw Nancy Lynn MD Snyderman paying a total of $74,240.00 for 45,650 shares, this is the most they've acquired in one year. In 2023 Nancy Lynn MD Snyderman cashed out on 7,387 shares for a total of $42,728.40, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Future Health ESG Corp. (FHLT) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.04%
-3.38K
—
—
22.51K
Oct 24
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found

Axonics Modulation Technologies, Inc. (AXNX) Snapshot price: $68.7655

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+17.71%
3K
—
—
19.94K
Jun 26
Form 4
+14.15%
2.1K
—
—
16.94K
Aug 18
Form 4
+17.97%
2.26K
—
—
14.84K
Oct 22
Form 4
+38.53%
3.5K
—
—
12.58K
Aug 24
Form 4
+29.76%
2.08K
—
—
9.08K
Aug 22
Form 4
+40.00%
2K
$37.12
$74,240.00
7K
Jun 27
Form 4
∞
5K
—
—
5K
Apr 8
Form 3
—
0
—
—
0
No matching records found

Alkermes plc. (ALKS) Snapshot price: $26.86

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4.64K
$24.10
-$35,306.50
4.64K
Jun 29
Form 4
—
0
—
—
0
Nov 17 - May 31
Form 4
+27.85%
4.53K
$29.88
-$42,728.40
20.78K
Jul 7
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jul 7
Form 4
+73.56%
6.89K
$27.19
-$18,897.05
16.26K
Jun 14
Form 4
+4.78%
427
$23.43
$10,004.61
9.37K
Mar 4
Form 4
+90.19%
4.24K
$22.11
-$29,605.29
8.94K
Dec 2
Form 4
—
0
—
—
0
Jun 14
Form 4
∞
4.7K
$21.92
-$30,775.68
4.7K
May 20
Form 4
—
0
—
—
0
Dec 2
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found

Lyra Therapeutics, Inc. (LYRA) Snapshot price: $0.2798

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
May 26
Form 4
∞
1.02K
$9.72
$9,963.00
1.02K
Dec 16
Form 4
—
0
—
—
0
Oct 27
Form 3
—
0
—
—
0
No matching records found